S

Active Director Director DIN 10700184
DIN 10700184 First appointment Jul 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Sumit

Data last updated:

Sumit is a Director at Sarvah Pharma Private Limited (since 2024). The company operates in Paper. Sarvah Pharma Private Limited reported revenue of ₹21.5 Lakh (FY 2025).

DIN 10700184
Primary Designation Director
Industry Paper
First Appointment 09 Jul 2024
Oldest Company Age 2 yrs
Largest company Sarvah Pharma Private Limited · ₹21.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sarvah Pharma Private Limited U21002DL2024PTC433929
Director09 Jul 20242024₹21.5 Lakh (FY 2025)Active

Board colleagues of Sumit

NameDINCompanyDesignation
Pooja10700183Sarvah Pharma Private LimitedDirector
Subhash11543713Sarvah Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Sarvah Pharma Private Limited
Premium access

Shareholding and investment profile for Sumit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit

Sumit currently holds 1 directorship: Sarvah Pharma Private Limited (Director, since 09 Jul 2024, revenue ₹21.5 Lakh (FY 2025)).

Sumit was first appointed on 09 Jul 2024 as Director at Sarvah Pharma Private Limited.

The current boards of Sumit's companies include Pooja (Sarvah Pharma Private Limited), Subhash (Sarvah Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available